Angel News

Angel News

Back to Homepage

13th November 2019

Biotherapy secures £3 million investment from Foresight

Foresight Group has made a £3 million investment into Biotherapy Services Limited, a biopharmaceutical company specialising in regenerative medicine for the treatment of complex wounds.  One of its products is currently undergoing a clinical trial for treating chronic diabetic foot ulcers (DFUs).  


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage